Pieter Drost serves as the Head of Market Access & Pricing - International at Exact Sciences, where he leverages over 20 years of extensive experience in the pharmaceutical and biotechnology sectors, with a particular focus on oncology. His role is pivotal in ensuring that patients...
Pieter Drost serves as the Head of Market Access & Pricing - International at Exact Sciences, where he leverages over 20 years of extensive experience in the pharmaceutical and biotechnology sectors, with a particular focus on oncology. His role is pivotal in ensuring that patients across all international markets can access innovative diagnostic solutions, including the Oncotype Dx test, which has transformed the landscape of personalized cancer treatment. Pieter leads a dynamic team dedicated to building a robust Market Access organization that encompasses Pricing, Health Policy, and Outcomes and Evidence capabilities. This strategic approach is designed to optimize access to current and future products, ensuring that they meet the diverse needs of patients and healthcare systems alike.
Pieter's expertise spans critical markets, including the US, EU5, Japan, Canada, Brazil, and Australia, where he has successfully navigated complex regulatory environments and reimbursement landscapes. His experience at the global headquarters level has equipped him with a deep understanding of economic modeling, health technology assessments (HTA), and evidence collection, all of which are essential for crafting effective market access strategies. As he looks to expand his team in 2024, Pieter is eager to connect with talented professionals who share his passion for enhancing patient access to life-changing therapies. His commitment to strategic management and team leadership continues to drive success at Exact Sciences, positioning the company as a leader in the oncology space. For those interested in joining this impactful mission, Pieter invites direct inquiries regarding opportunities within his expanding team.
